Protective Actions of PPAR-γ Activation in Renal Endothelium

por Westerweel, Peter E., Verhaar, Marianne C.
Publicado 2008

Disseminated cryptococcal disease during treatment with idelalisib and corticosteroids for follicular lymphoma

por Hengeveld, Paul J, de Jongh, Eva, Westerweel, Peter E, Levin, Mark-David
Publicado 2020

New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia

por Westerweel, Peter E., te Boekhorst, Peter A. W., Levin, Mark-David, Cornelissen, Jan J.
Publicado 2019

Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study

por Ector, Geneviève I. C. G., Huijskens, Elisabeth G. W., Blijlevens, Nicole M. A., Westerweel, Peter E.
Publicado 2020

ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling

por Westerweel, Peter E., Joles, Jaap A., den Ouden, Krista, Goldschmeding, Roel, Rookmaaker, Maarten B., Verhaar, Marianne C.
Publicado 2012

Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice

por Kockerols, Camille C.B., Valk, Peter J.M., Levin, Mark-David, Pallisgaard, Niels, Cornelissen, Jan J., Westerweel, Peter E.
Publicado 2020

Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus

por Westerweel, Peter E., Teraa, Martin, Rafii, Shahin, Jaspers, Janneke E., White, Ian A., Hooper, Andrea T., Doevendans, Pieter A., Verhaar, Marianne C.
Publicado 2013

Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study

por Visser, Chantal, Kruip, Marieke J. H. A., Brantsma-Van der Graaf, Janet, van Thiel, Eric E., Levin, Mark-David, Westerweel, Peter E.
Publicado 2023

Bone Marrow Alterations and Lower Endothelial Progenitor Cell Numbers in Critical Limb Ischemia Patients

por Teraa, Martin, Sprengers, Ralf W., Westerweel, Peter E., Gremmels, Hendrik, Goumans, Marie-José T. H., Teerlink, Tom, Moll, Frans L., Verhaar, Marianne C.
Publicado 2013

Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model

por Westerweel, Peter E, van Velthoven, Cindy TJ, Nguyen, Tri Q, den Ouden, Krista, de Kleijn, Dominique PV, Goumans, Marie Jose, Goldschmeding, Roel, Verhaar, Marianne C
Publicado 2010

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

por Kockerols, Camille C.B., Geelen, Inge, Levin, Mark-David, Janssen, Jeroen J.W.M., Dinmohamed, Avinash G., Hoogendoorn, Mels, Cornelissen, Jan J., Westerweel, Peter E.
Publicado 2022

Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia

por Geelen, Inge G.P., Thielen, Noortje, Janssen, Jeroen J.W.M., Hoogendoorn, Mels, Roosma, Tanja J.A., Willemsen, Sten P., Visser, Otto, Cornelissen, Jan J., Westerweel, Peter E.
Publicado 2017

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach

por Ector, Geneviève ICG, Westerweel, Peter E, Hermens, Rosella PMG, Braspenning, Karin AE, Heeren, Barend CM, Vinck, Oscar MF, de Jong, Jan JM, Janssen, Jeroen JWM, Blijlevens, Nicole MA
Publicado 2020

Association Between Geriatric Assessment and Post-Chemotherapy Functional Status in Older Patients with Cancer

por Rier, Hánah N, Meinardi, Marieke C, van Rosmalen, Joost, Westerweel, Peter E, de Jongh, Eva, Kitzen, Jos J E M, van den Bosch, Joan, Trajkovic, Marija, Levin, Mark-David
Publicado 2022

High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population

por Kockerols, Camille C.B., Geelen, Inge G.P., Levin, Mark-David, Janssen, Jeroen J.W.M., Beverloo, H. Berna, Dinmohamed, Avinash G., Hoogendoorn, Mels, Cornelissen, Jan J., Westerweel, Peter E.
Publicado 2023

The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population‐based study in the Netherlands, 1989–2018

por Maas, Carolien C. H. M., van Klaveren, David, Ector, Geneviève I. C. G., Posthuma, Eduardus F. M., Visser, Otto, Westerweel, Peter E., Janssen, Jeroen J. W. M., Blijlevens, Nicole M. A., Dinmohamed, Avinash G.
Publicado 2021

Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate

por Bavalia, Roisin, Abdoellakhan, Rahat, Brinkman, Herm Jan M., Brekelmans, Marjolein P. A., Hamulyák, Eva N., Zuurveld, Marleen, Hutten, Barbara A., Westerweel, Peter E., Olie, Renske H., ten Cate, Hugo, Kruip, Marieke, Middeldorp, Saskia, Meijer, Karina, Coppens, Michiel
Publicado 2020

Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib

por Boons, Christel C. L. M., Timmers, Lonneke, Janssen, Jeroen J. W. M., Westerweel, Peter E., Blijlevens, Nicole M. A., Smit, Willem M., Bartelink, Imke H., Wilschut, Janneke A., Swart, Eleonora L., Hendrikse, N. Harry, Hugtenburg, Jacqueline G.
Publicado 2020

Prognosis of IGLV3-21(R110) chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

por Hengeveld, Paul J., Veelken, Hendrik, van Bergen, Cornelis A. M., Quinten, Edwin, Vervoordeldonk, Mischa Y. L., Ismailzada, Wahija, Barendse, Rob S., Dubois, Julie M. N., van Oers, Marinus H. J., Geisler, Christian H., Kater, Arnon P., Westerweel, Peter E., Langerak, Anton W., Levin, Mark-David
Publicado 2023

The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia

por Visser, Chantal, Swinkels, Maurice, van Werkhoven, Erik D., Croles, F. Nanne, Noordzij, Heike, Eefting, Matthijs, Last-Koopmans, Suzanne M., Idink, Cecile, Westerweel, Peter E., Santbergen, Bart, Jobse, Pieter A., Baboe, Fazil, Consortium, Recovac-IR, Levin, Mark-David, Kruip, Marieke J.H.A., Jansen, A.J. Gerard
Publicado 2021